# Safety of High-dose Tirofiban During Coronary Angioplasty

> **NCT00566891** · PHASE4 · COMPLETED · sponsor: **S. Anna Hospital** · enrollment: 2000 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** tirofiban
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00566891
- **Lead sponsor:** S. Anna Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-07
- **Final completion:** 2009-02
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2011-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00566891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00566891, "Safety of High-dose Tirofiban During Coronary Angioplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00566891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*